Abstract: The present disclosure relates to techniques for transitioning between imagery and sounds of two different environments, such as a virtual environment and a real environment. A view of a first environment and audio associated with the first environment are provided. In response to detecting a transition event, a view of the first environment combined with a second environment is provided. The combined view includes imagery of the first environment at a first visibility value and imagery of the second environment at a second visibility value. In addition, in response to detecting a transition event, the first environment audio is mixed with audio associated with the second environment.

Abstract: The present disclosure relates to techniques for presenting a combined view of a virtual environment and a real environment in response to detecting a transition event associated with an object in the real environment. While presenting the combined view, if an input of a first type is detected, the combined view is adjusted by increasing the visibility of imagery of the virtual environment and decreasing the visibility of imagery of the real environment. If an input of a second type is detected, the combined view is adjusted by decreasing the visibility of the imagery of the virtual environment and increasing the visibility of the imagery of the real environment.

Abstract: The present disclosure relates to techniques for inserting imagery from a real environment into a virtual environment. While presenting (e.g., displaying) the virtual environment at an electronic device, a proximity of the electronic device to a physical object located in a real environment is detected. In response to detecting that the proximity of the electronic device to the physical object is less than a first threshold distance, imagery of the physical object is isolated from other imagery of the real environment. The isolated imagery of the physical object is inserted into the virtual environment at a location corresponding to the location of the physical object in the real environment. The imagery of the physical object has a first visibility value associated with the proximity of the electronic device to the physical object.

Abstract: The present disclosure relates to techniques for transitioning between imagery and sounds of two different environments, such as a virtual environment and a real environment. A view of a first environment and audio associated with the first environment are provided. In response to detecting a transition event, a view of the first environment combined with a second environment is provided. The combined view includes imagery of the first environment at a first visibility value and imagery of the second environment at a second visibility value. In addition, in response to detecting a transition event, the first environment audio is mixed with audio associated with the second environment.

Abstract: The present disclosure relates to techniques for inserting imagery from a real environment into a virtual environment. While presenting (e.g., displaying) the virtual environment at an electronic device, a proximity of the electronic device to a physical object located in a real environment is detected. In response to detecting that the proximity of the electronic device to the physical object is less than a first threshold distance, imagery of the physical object is isolated from other imagery of the real environment. The isolated imagery of the physical object is inserted into the virtual environment at a location corresponding to the location of the physical object in the real environment. The imagery of the physical object has a first visibility value associated with the proximity of the electronic device to the physical object.

Abstract: Compounds of Formula (I) wherein n, m, R1, R2, R3, R4, R5 and R6 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of Formula (I) wherein n, m, R1, R2, R3, R4, R5 and R6 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.

Abstract: Chloromethylpyridine hydrochlorides such as 3-chloromethylpyridine hydrochloride, an important pharmaceutical intermediate, are prepared in high yield and high purity by reacting the corresponding pyridyl carbinol with a slight excess of thionyl chloride, in solution in an inert solvent such as toluene. The pyridyl carbinol solution is added to the thionyl chloride gradually and under its surface, to prevent the formation of impurities. The product is recovered by applying vacuum or nitrogen purge to the reaction mixture to assist precipitation, followed by filtration and washing.